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Keywords: desmoglein 1; cadherins; pemphigus; autoimmunity; polymorphism Pemphigus foliaceus (PF) is a cutaneous autoimmune blistering disease 1 in which genetic factors play a role in disease susceptibility. An association with MHC class II genes has been described, 2 but other genes probably also contribute to the occurrence of PF as demonstrated in various autoimmune diseases. 3 Because desmoglein 1 (Dsg1), 4 a desmosomal adhesion glycoprotein, is the target of pathogenic PF autoantibodies and has been found to be polymorphic in bovine, 5 we examined whether the human desmoglein 1 gene (DSG1) is polymorphic and constitutes a candidate gene predisposing to PF.
Direct sequencing of genomic DNA obtained from 36 Caucasian patients with PF enabled us to identify a first polymorphic marker in the region corresponding to exon 11 known to be polymorphic in bovine. This region encodes the fifth and part of the fourth extracellular domains (EC4-EC5) of the protein as well as part of the transmembrane domain (TM) (Figure 1 ). The polymorphic marker was made of five mis-sense mutations (A→C substitution at position 1555, C→A substitution at position 1570, A→C substitution at position 1660, AAAGA→AGAAA inversion at positions 1686-1690), forming a unique variant haplotype ( Figure 1 ). This haplotype was observed in five patients, was always heterozygous, and was inherited according to mendelian transmission ( Figure 2 PCR products (100 fmol), purified by low-meltingpoint agarose-gel electrophoresis, were used for direct sequencing with the Thermosequenase-Radiolabeled Terminator Cycle Sequencing Kit (Amersham, Cleveland, OH, USA) using the F1 and R1 primers. The five mutations were always associated in a same patient. In one mutated patient, PCR products were subcloned into a pCR quency was determined by allele-specific PCR in 118 healthy Caucasian controls (Figure 3 ). Allelic distribution did not differ significantly between patients and controls ( Table 1) .
By sequencing patients' cDNA encoding most of the extracellular domains of Dsg1 (EC2-EC5), a second polymorphic marker was identified in the region encoding the second extracellular domain (EC2) that consists of a single silent T to C transition at position 809. Its frequency was determined by PCR-RFLP (Figure 4) . Allelic distribution differed significantly between patients and controls (Table 1) .
DSG1 polymorphic marker distribution did not differ among PF patients according to sex, clinical presentation or presence of anti-Dsg1 antibodies detected by immunoblotting using human keratinocyte extract. However, patients homozygous for mutation 809 were younger than others (mean age 47.5 years vs 62.4 years); 12/15 patients homozygous for mutation 809 were р60 years, while only 8/21 patients non-homozygous for mutation 809 were р60 years ( 2 , 1df = 6.22, P = 0.03 with Yates correction).
These data demonstrate that: (i) the coding sequence of DSG1 is polymorphic; (ii) EC4-EC5 encoding region polymorphism does not constitute an independent susceptibility factor to PF; (iii) the region encoding EC2 is polymorphic and appears to be involved in PF susceptibility. Interestingly, preliminary results indicate a highly significant increase of homozygous mutation 809 in the subgroup of HLA class II DR4 patients, a generic significantly associated with PF (data not shown), suggesting a combination of two complex trait loci (DSG1 and MHC class II) in PF susceptibility. So far, involvement of auto- , 1df = 5.972).
Figure 3
Allele-specific PCR for detection of mutation 1660. For rapid detection of the newly identified haplotype on exon 11 among healthy controls, an AS-PCR was used that enabled detection of mutation 1660 by a single-step triplex PCR. In this procedure, four primers were used, the two external ones were not allele-specific (F1, R1) and the two internal ones were inversely-oriented and had their 3Ј-extremities at the mutation 1660 position (Fw: 5Ј-TTCTACTGACTCTAGCCAAGTATA-3Ј at antigen polymorphism has been reported in two other autoimmune diseases, insulin-dependent diabetes melitus (VNTR polymorphism upstream of the insulin gene 6 ) and myasthenia gravis (microsatellite polymorphism in the first intron of the CHRNA gene 7 ), whose significance still remains poorly understood. Several hypotheses may account for the role of a silent mutation of the coding sequence of Dsg1 in PF: an association with another polymorphism located elsewhere on the regulatory or coding sequences of DSG1, or an involvement of the mutation in splicing regulation. 8 Preliminary results favor the former hypothesis. Indeed, though alternative spliced mRNAs of DSG1 containing a 101 bp insertion made of the 3Ј extremity of intron 6 that leads to a premature stop codon were detected by RT-PCR from keratinocytes obtained from 14 individuals, they were present in subjects with or without mutation 809.
Thus, PF constitutes another example of polygenic organ-specific autoimmune disease in which polymorphism of the autoantigen takes part in disease susceptibility.
